RedHotStocks

$TXMD TherapeuticsMD.inc no cure in sight for longs.

Penjualan
NASDAQ:TXMD   TherapeuticsMD, Inc.
Not really a household name among investors but well known to the ever growing of shorts. As of March 26th there was a 38% short interest. Despite FDA approval for 3 new drugs sales have been dismal and the company has increased expenditure on sales to tackle the issue, thus driving operating expenses much higher. The price currently sits at $4.57 well below the analysts average target of $15 which is hard to explain. Like any stock in the drug manufacturing sector the price can spike very quickly, so if your shorting keep stop losses very tight.

Pernyataan Penyangkalan

Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.